Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
5
×
boston blog main
boston top stories
life sciences
national blog main
san francisco blog main
5
×
biotech
national top stories
deals
san francisco top stories
startups
vc
clinical trials
dna
fda
investing
new york blog main
software
venture capital
agios therapeutics
andreessen horowitz
arrowmark partners
athenahealth
azacitidine
barack obama
base editing
beta bionics
beta-thalassemia
bigfoot biomedical
bill frist
biofourmis
biovotion
boston university
branden moriarty
broad institute
cas13
castlight health
chugai pharmaceutical
congenital hyperinsulinism
crispr therapeutics
What
startup
5
×
million
therapeutics
approach
called
developing
patients
aims
analytics
andreessen
answer
based
beam
beta
biofourmis
bionics
biotech
blood
cas
closed
crispr
data
debuts
device
devices
devoted
diabetes
digital
driven
drugs
editas
editing
editor
employs
epigenetic
epigenetics
field
fix
flagship’s
founders
Language
unset
Current search:
boston
×
startup
×
" san francisco blog main "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Andreessen Leads $300M Bet on Devoted Health’s Senior Care Approach
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M